№ lp_2_3_60832
File format: docx
Character count: 7438
File size: 125 KB
Year:
2022
Region / city:
EU
Theme:
Pharmacovigilance
Document type:
Report
Organization:
European Medicines Agency (EMA)
Author:
PRAC
Target audience:
Healthcare professionals, regulatory authorities
Period of validity:
N/A
Date of approval:
DD Month YYYY
Date of modifications:
N/A
Contextual description:
Report providing detailed information on signal assessment and recommendations related to pharmacovigilance procedures for a specific safety signal in the EU.
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2015
Type of document:
Assessment report template
Subject:
Pharmacovigilance, Periodic Safety Update Reports (PSUR)
Organization:
European Medicines Agency (EMA)
Target audience:
Lead Member States, MAHs, PRAC members
Procedure number:
Not specified
Data lock point:
Not specified
Status:
Guidance and procedural template
References:
GVP Module V, VII, VIII; Variations Classification guideline Commission Regulation 1234/2008; HMA/EMEA recommendations EMEA/743133/2009
Date:
14 October 2016
Document type:
Stakeholder comments
Subject:
Good pharmacovigilance practices
Guideline reference:
GVP Module VI (Rev 2)
Regulatory framework:
European Union pharmacovigilance legislation
Organisation:
European Federation of Pharmaceutical Industries and Associations (EFPIA)
Author:
Sini Eskola
Recipient institution:
European Medicines Agency
Related standards:
ICH E2B (R2), ICH E2B (R3)
Key topics:
Individual Case Safety Reports, adverse reaction reporting, EudraVigilance, validation rules, terminology consistency
Position of author:
Industry stakeholder
Public disclosure status:
Intended for publication by the Agency
Year:
2026
Region / city:
European Union
Subject:
Pharmacovigilance
Document Type:
Final Study Report
Organization / Institution:
European Medicines Agency (EMA)
Author:
PRAC Rapporteur
Target Audience:
EMA committee members, Marketing Authorisation Holders (MAH)
Period of Validity:
Until completion of procedure
Date of Approval:
2026-02-24
Date of Changes:
None
Year:
2011
Region / City:
Madagascar
Topic:
Health, Pharmacovigilance
Document Type:
Policy
Organization:
Ministry of Public Health, Madagascar
Author:
Ministry of Public Health
Target Audience:
Health professionals, stakeholders in health development
Effective Period:
Not specified
Approval Date:
October 2011
Amendment Date:
Not specified
Year:
2014
Organization:
EFPIA
Author:
Sini Eskola
Recipient:
European Medicines Agency (EMA)
Document type:
Comment submission
Subject:
Public hearings procedures at PRAC
Regulation reference:
Regulation 726/2004, Directive 2001/83/EC
Intended audience:
EMA, stakeholders in pharmacovigilance
Date submitted:
15 October 2014
Format:
Word document
Mode of submission:
Electronic
Stakeholder number:
Not assigned
Note:
Year
Region / city:
Amsterdam
Type of document:
Assessment report
Committee / organization:
Committee for Medicinal Products for Human Use (CHMP), Pharmacovigilance Risk Assessment Committee (PRAC)
Procedure number:
EMEA/H/C/
Rapporteurs:
CHMP Rapporteur, PRAC Rapporteur
Product type:
Generic/hybrid medicinal product
Confidential information included:
Yes / No
Year:
2015
Type of document:
Assessment report template
Subject:
Pharmacovigilance, Periodic Safety Update Reports (PSUR)
Organization:
European Medicines Agency (EMA)
Target audience:
Lead Member States, MAHs, PRAC members
Procedure number:
Not specified
Data lock point:
Not specified
Status:
Guidance and procedural template
References:
GVP Module V, VII, VIII; Variations Classification guideline Commission Regulation 1234/2008; HMA/EMEA recommendations EMEA/743133/2009
Year:
2026
Region / city:
European Union
Subject:
Pharmacovigilance
Document Type:
Final Study Report
Organization / Institution:
European Medicines Agency (EMA)
Author:
PRAC Rapporteur
Target Audience:
EMA committee members, Marketing Authorisation Holders (MAH)
Period of Validity:
Until completion of procedure
Date of Approval:
2026-02-24
Date of Changes:
None
Year:
2025
Region / City:
New Mexico
Topic:
Energy Rate Design
Document Type:
Meeting Notes
Organization / Institution:
PNM
Author:
Not specified
Target Audience:
PNM staff, stakeholders, and energy industry professionals
Effective Date:
August 2025
Date of Approval:
Not specified
Date of Changes:
Not specified
Year:
2025
Date of meeting:
April 22, 2025
Time:
2:00 p.m.
Location:
GMSC Boardroom, 1773 Water Street (lower level, accessible from Loggie Drive), Miramichi
Region / City:
Miramichi, New Brunswick, Canada
Organization:
Greater Miramichi Service Commission
Committee:
Planning Review and Adjustment Committee (PRAC)
Document type:
Meeting agenda
Meeting number:
2025-1
Agenda items:
Approval of agenda; Approval of minutes (Meetings 2024-9 and 2024-10); Selection of Chairperson and Vice-Chairperson; Declaration of conflict of interest; Review of tentative subdivision plan
Applicant:
Randy Waye, T.G. Williston Surveys Ltd.
Staff presenter:
Julien Robichaud, Development Officer
Project:
RAS CAN–IND Ltd. Subdivision — Plan 2025-1
Area concerned:
St. Margarets, Parish of Glenelg
Legal reference:
New Brunswick Regulation 80-159 under the Community Planning Act (c.19)
Purpose:
Committee review and advice regarding proposed future access related to a subdivision plan
Remote access:
MS Teams meeting link with Meeting ID and passcode
Year:
2014
Organization:
EFPIA
Author:
Sini Eskola
Recipient:
European Medicines Agency (EMA)
Document type:
Comment submission
Subject:
Public hearings procedures at PRAC
Regulation reference:
Regulation 726/2004, Directive 2001/83/EC
Intended audience:
EMA, stakeholders in pharmacovigilance
Date submitted:
15 October 2014
Format:
Word document
Mode of submission:
Electronic
Stakeholder number:
Not assigned
Date:
Thursday, September 18, 2025
Year:
2025
Region / City:
United States
Topic:
Passenger Rail, Liability, Insurance
Document Type:
Meeting Minutes
Organization:
Surface Transportation Board (STB)
Authors:
Brian O’Boyle, Henry Posner, Jim Derwinski, Lori Winfree, etc.
Target Audience:
PRAC members, STB staff, industry stakeholders
Period of Action:
September 18, 2025
Date of Approval:
N/A
Date of Amendments:
N/A
Year:
2023
Region / city:
Not specified
Topic:
Psychiatry / Case Presentation
Document Type:
Assignment Instructions
Author:
Not specified
Target audience:
Medical/Clinical students
Period of validity:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Context description:
Assignment instructions for creating a focused SOAP note and developing a patient case presentation, with an emphasis on psychiatric assessment and treatment planning.
Year:
2013, 2019
Region / City:
United States
Topic:
Signal Strength, Installation Standards, Communication Systems
Document Type:
Standard
Organization / Institution:
National Fire Protection Association (NFPA)
Author:
National Fire Protection Association (NFPA)
Target Audience:
Engineers, designers, and professionals in the field of fire alarm systems and communication enhancements
Period of Validity:
Ongoing
Approval Date:
Not specified
Amendments Date:
Not specified
Year:
2021
Region / city:
United States
Topic:
Railroad safety regulations, Positive Train Control (PTC) systems
Document type:
Final rule
Authority/Institution:
Federal Railroad Administration (FRA)
Author:
Federal Railroad Administration
Target audience:
Railroads, railroad industry professionals, regulators
Period of action:
From July 27, 2021, onwards
Approval date:
July 27, 2021
Amendment date:
Not specified
Year:
2022
Region / city:
Australia
Theme:
Application Conformance Test
Document type:
Checklist
Organ / institution:
ASX
Author:
ASX
Target audience:
Customers involved in conformance testing
Period of validity:
Not specified
Approval date:
May 2022
Date of changes:
May 2022
Year:
2026
Organization:
ITU – Telecommunications Standardization Sector, Study Group 21, Video Coding Experts Group (VCEG)
Document Type:
Proposal / Technical Contribution
Authors:
Yago Sanchez de la Fuente, Heiner Kirchhoffer, Jonathan Pfaff, Heiko Schwarz, Cornelius Hellge, Thomas Schierl, Detlev Marpe, Thomas Wiegand
Meeting:
78th Meeting, 13–23 January 2026, Virtual
Email:
[email protected]
Scope:
Specification of carriage, decoder configuration, and sample entry structure for biomedical and general waveform signal coding in ISO base media file format
Year:
2021
Region / City:
European Union
Topic:
Veterinary Pharmacovigilance
Document Type:
Guidance Document
Authoring Organization:
European Medicines Agency (EMA)
Target Audience:
Marketing Authorisation Holders (MAHs)
Period of Validity:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Description:
This document provides a template for Marketing Authorisation Holders (MAHs) to assess signals detected and validated in the Union Pharmacovigilance database (EudraVigilance Veterinary).